Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02081508 · ClinicalTrials.gov registry record · NA

Consolidation & Interference in Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by Kessler Foundation.

Completed
Registry status
NA
Development phase
39
Enrollment target
1
Study location

NCT02081508 is a NA study of Multiple Sclerosis that has completed, run by Kessler Foundation. The registered enrollment target is 39 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02081508, a NA study of Multiple Sclerosis, has completed, sponsored by Kessler Foundation.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to investigate whether minimizing interference improves memory in multiple sclerosis.

Conditions Studied

Interventions

  • BEHAVIORAL Interference onset

Study Locations (1)

New Jersey

  • Kessler Foundation - West Orange

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2014-03
Est. Completion 2015-05
Phase NA

Sponsor

Kessler Foundation

104 total trials

What the Registry Record Tells You About NCT02081508

The ClinicalTrials.gov registry entry for NCT02081508 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (93% lower). The listed sponsor is Kessler Foundation, which has 104 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Interference onset is the first listed.

NCT02081508 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT02081508 about?

NCT02081508 is a clinical study titled "Consolidation & Interference in Multiple Sclerosis". The purpose of this research study is to investigate whether minimizing interference improves memory in multiple sclerosis.

What is the current status of trial NCT02081508?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2014-03. Estimated completion is 2015-05.

What conditions does trial NCT02081508 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT02081508?

The interventions under investigation include: Interference onset (BEHAVIORAL).

Who is sponsoring clinical trial NCT02081508?

This trial is sponsored by Kessler Foundation, which has 104 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02081508 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.